Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006
Published online before print October 12, 2006, doi: 10.1161/01.RES.0000250046.69918.d5
A more recent version of this article appeared on November 10, 2006
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
99/10/1084    most recent
01.RES.0000250046.69918.d5v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nikolaev, V. O.
Right arrow Articles by Engelhardt, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nikolaev, V. O.
Right arrow Articles by Engelhardt, S.
Related Collections
Right arrow Other heart failure
Right arrow Receptor pharmacology
Right arrowRelated Article

Submitted on July 28, 2006
Revised on October 4, 2006
Accepted on October 4, 2006

Cyclic AMP Imaging in Adult Cardiac Myocytes Reveals Far-Reaching {beta}1-Adrenergic but Locally Confined {beta}2-Adrenergic Receptor-Mediated Signaling

Viacheslav O. Nikolaev ; Moritz Bünemann ; Eva Schmitteckert ; Martin J. Lohse ; and Stefan Engelhardt *

From the Institute of Pharmacology and Toxicology (V.O.N., M.B., E.S., M.J.L.), University of Wuerzburg; and Rudolf-Virchow-Center (S.E.), Deutsche Forschungsgemeinschaft-Research Center for Experimental Biomedicine, University of Wuerzburg, Germany.

* To whom correspondence should be addressed. E-mail: stefan.engelhardt{at}virchow.uni-wuerzburg.de.

{beta}1- and {beta}2-adrenergic receptors ({beta}ARs) are known to differentially regulate cardiomyocyte contraction and growth. We tested the hypothesis that these differences are attributable to spatial compartmentation of the second messenger cAMP. Using a fluorescent resonance energy transfer (FRET)-based approach, we directly monitored the spatial and temporal distribution of cAMP in adult cardiomyocytes. We developed a new cAMP-FRET sensor (termed HCN2-camps) based on a single cAMP binding domain of the hyperpolarization activated cyclic nucleotide-gated potassium channel 2 (HCN2). Its cytosolic distribution, high dynamic range, and sensitivity make HCN2-camps particularly well suited to monitor subcellular localization of cardiomyocyte cAMP. We generated HCN2-camps transgenic mice and performed single-cell FRET imaging on freshly isolated cardiomyocytes. Whole-cell superfusion with isoproterenol showed a moderate elevation of cAMP. Application of various phosphodiesterase (PDE) inhibitors revealed stringent control of cAMP through PDE4>PDE2>PDE3. The {beta}1AR-mediated cAMP signals were entirely dependent on PDE4 activity, whereas {beta}2AR-mediated cAMP was under control of multiple PDE isoforms. {beta}1AR subtype-specific stimulation yielded {approx}2-fold greater cAMP responses compared with selective {beta}2-subtype stimulation, even on treatment with the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine (IBMX) ({Delta}FRET, 8.8±0.4% [{beta}2AR] versus 17.3±1.3% [{beta}1AR]). Treatment with pertussis toxin to inactivate Gi did not affect cAMP production. Localized {beta}1AR stimulation generated a cAMP gradient propagating throughout the cell, whereas local {beta}2AR stimulation did not elicit marked cAMP diffusion. Our data reveal that in adult cardiac myocytes, {beta}1ARs induce far-reaching cAMP signals, whereas {beta}2AR-induced cAMP remains locally confined.


Key words: cAMP • FRET • cardiomyocyte • {beta}-adrenergic receptor


Related Article:

FRETting Mice Shed Light on Cardiac Adrenergic Signaling
Lisa M. DiPilato and Jin Zhang
Circ. Res. 2006 99: 1021-1023. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
F. Vandeput, J. Krall, R. Ockaili, F. N. Salloum, V. Florio, J. D. Corbin, S. H. Francis, R. C. Kukreja, and M. A. Movsesian
cGMP-Hydrolytic Activity and Its Inhibition by Sildenafil in Normal and Failing Human and Mouse Myocardium
J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 884 - 891.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Soto, V. De Arcangelis, J. Zhang, and Y. Xiang
Dynamic Protein Kinase A Activities Induced by {beta}-Adrenoceptors Dictate Signaling Propagation for Substrate Phosphorylation and Myocyte Contraction
Circ. Res., March 27, 2009; 104(6): 770 - 779.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. De Arcangelis, D. Soto, and Y. Xiang
Phosphodiesterase 4 and Phosphatase 2A Differentially Regulate cAMP/Protein Kinase A Signaling for Cardiac Myocyte Contraction under Stimulation of {beta}1 Adrenergic Receptor
Mol. Pharmacol., November 1, 2008; 74(5): 1453 - 1462.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. V. Iancu, G. Ramamurthy, S. Warrier, V. O. Nikolaev, M. J. Lohse, S. W. Jones, and R. D. Harvey
Cytoplasmic cAMP concentrations in intact cardiac myocytes
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C414 - C422.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. A. Kass
Message Delivered: How Myocytes Control cAMP Signaling
Circ. Res., May 9, 2008; 102(9): 1002 - 1004.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. Leroy, A. Abi-Gerges, V. O. Nikolaev, W. Richter, P. Lechene, J.-L. Mazet, M. Conti, R. Fischmeister, and G. Vandecasteele
Spatiotemporal Dynamics of {beta}-Adrenergic cAMP Signals and L-Type Ca2+ Channel Regulation in Adult Rat Ventricular Myocytes: Role of Phosphodiesterases
Circ. Res., May 9, 2008; 102(9): 1091 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Tsujikawa, Y. Song, M. Watanabe, H. Masumiya, S. A. Gupte, R. Ochi, and T. Okada
Cholesterol depletion modulates basal L-type Ca2+ current and abolishes its -adrenergic enhancement in ventricular myocytes
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H285 - H292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Willoughby, G. S. Baillie, M. J. Lynch, A. Ciruela, M. D. Houslay, and D. M. F. Cooper
Dynamic Regulation, Desensitization, and Cross-talk in Discrete Subcellular Microdomains during beta2-Adrenoceptor and Prostanoid Receptor cAMP Signaling
J. Biol. Chem., November 23, 2007; 282(47): 34235 - 34249.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Vandeput, S. L. Wolda, J. Krall, R. Hambleton, L. Uher, K. N. McCaw, P. B. Radwanski, V. Florio, and M. A. Movsesian
Cyclic Nucleotide Phosphodiesterase PDE1C1 in Human Cardiac Myocytes
J. Biol. Chem., November 9, 2007; 282(45): 32749 - 32757.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Zaccolo and M. A. Movsesian
cAMP and cGMP Signaling Cross-Talk: Role of Phosphodiesterases and Implications for Cardiac Pathophysiology
Circ. Res., June 8, 2007; 100(11): 1569 - 1578.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. D. Houslay, G. S. Baillie, and D. H. Maurice
cAMP-Specific Phosphodiesterase-4 Enzymes in the Cardiovascular System: A Molecular Toolbox for Generating Compartmentalized cAMP Signaling
Circ. Res., April 13, 2007; 100(7): 950 - 966.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Merkle, S. Frantz, M. P. Schon, J. Bauersachs, M. Buitrago, R. J.A. Frost, E. M. Schmitteckert, M. J. Lohse, and S. Engelhardt
A Role for Caspase-1 in Heart Failure
Circ. Res., March 16, 2007; 100(5): 645 - 653.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. M. DiPilato and J. Zhang
FRETting Mice Shed Light on Cardiac Adrenergic Signaling
Circ. Res., November 10, 2006; 99(10): 1021 - 1023.
[Full Text] [PDF]